Data / Form D filings / Niche Biopharmaceuticals LLC
Niche Biopharmaceuticals LLC: Form D filings
Niche Biopharmaceuticals LLC, a pharmaceuticals company in Shorewood, MN, filed 4 Form D notices with the SEC between 2021 and 2026. The latest, on May 11, 2026, reports $200,000 sold of a $200,000 offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 22345 BRACKETTS ROAD, Shorewood, MN, 55331
- Phone
- (952) 474-9628
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1846144
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | New notice | $200,000 | $200,000 | 4 | Apr 20, 2026 | sec.gov | |
| May 9, 2025 | New notice | $100,000 | $100,000 | 2 | Apr 30, 2025 | sec.gov | |
| Feb 6, 2023 | New notice | $200,000 | $200,000 | 5 | Jan 20, 2023 | sec.gov | |
| Feb 17, 2021 | New notice | $310,000 | $25,000 | $285,000 | 1 | Feb 2, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Dayton Reardan | Executive Officer, Director, Promoter | |
| Daniel Saccani | Director | Manager |
| Paul Brennan | Director | Manager |
| Patrick Schlievert | Director | Manager |
| Robert Klem | Director | Manager |
Every Form D from the week of May 11, 2026 · All recent filings in Minnesota · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Niche Biopharmaceuticals LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.